CI_MoA CI_with has_Ingredient has_MoA has_PE may_prevent may_treat drug associated with AE in adult used to treat disease Immunologic Adjuvants [MoA] Arthritis, Rheumatoid [Disease/Finding] Drug Hypersensitivity [Disease/Finding] Glomerulosclerosis, Focal Segmental [Disease/Finding] Graft vs Host Disease [Disease/Finding] Hypertension [Disease/Finding] Lupus Erythematosus, Systemic [Disease/Finding] Myasthenia Gravis [Disease/Finding] Neoplastic Processes [Disease/Finding] Psoriasis [Disease/Finding] Kidney Failure [Disease/Finding] Cyclosporine [Chemical/Ingredient] Decreased Cytokine Activity [PE] Decreased Cytokine Production [PE] Decreased T Lymphocyte Production [PE] Unknown Cellular or Molecular Interaction [MoA] Lactation [Disease/Finding] C [Preparations] CYCLOSPORINE http://www.accessdata.fda.gov/drugsatfda_docs/label/2009/050715s028,050716s029lbl.pdf Cyclosporine N0000147064 83HN0GTJ6D C13348 4018761 <VANDF_Record>50.416^1363^</VANDF_Record><VA_File>50.416</VA_File><VA_IEN>1363</VA_IEN> Ingredient C0010592 CYCLOSPORINE <VANDF_Record>50.6^1100^</VANDF_Record><VA_File>50.6</VA_File><VA_IEN>1100</VA_IEN> 3008 Active rheumatoid arthritis psoriasis fatigue AE headache AE paresthesia AE flu syndrome AE abdominal pain AE hypertension AE nausea AE vomiting AE constipation AE diarrhea AE musculoskeletal pain AE hypertriglyceridemia AE renal dysfunction AE heartburn AE hypertrichosis AE stomach pain AE